Those gains over January, when the drugs fell to third and fourth on the list, came even as spending dropped for both meds: AbbVie spent $34.8 million on Rinvoq’s TV ads and $27 million on ...

According to iSpot.tv data, prescription drug brands in 2024 accounted for 11.6% of all linear-TV ad spend (a catch-all ...

Rinvoq (upadacitinib) is a prescription drug that works to treat certain inflammatory conditions by decreasing the activity of immune system cells. Your response to this drug may vary based on ...

Patients in the EU with giant cell arteritis (GCA), an inflammation of the arteries, could soon have the first oral targeted treatment for the disease after AbbVie's Rinvoq was recommended for ...

A European Commission committee is recommending AbbVie's Rinvoq for treatment of giant cell arteritis following Phase 3 clinical trial results that showed efficacy and safety in the inflammatory ...